 |
 |
Our Partners
|
|
|
|
||||
|
|
|
||
|
|
||||
In 1999, STORZ MEDICAL was the first manufacturer worldwide to introduce a cardiological shock wave system for the treatment of refractory angina pectoris. During the last few years, the company has conducted ongoing research in close co-operation with leading medical institutes and continuously improved shock wave therapy for cardiological applications.
Today, many renowned therapy centres use the innovative MODULITH® SLC with great success in the treatment of Non-revascularizable Angina Pectoris, Ischemic Heart Disease (HF), No-reflow after PCI, Diffuse Coronary Artery Disease.
o MODULITH® SLC
• DENOLGA MEDICAL © 2007 - 2014 •